Review
Version 1
Preserved in Portico This version is not peer-reviewed
Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice
Version 1
: Received: 31 August 2020 / Approved: 2 September 2020 / Online: 2 September 2020 (06:04:17 CEST)
A peer-reviewed article of this Preprint also exists.
Aggarwal, P.; Woolford, S.J.; Patel, H.P. Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics 2020, 5, 85. Aggarwal, P.; Woolford, S.J.; Patel, H.P. Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics 2020, 5, 85.
Abstract
Multi-morbidity and polypharmacy are common in older people and pose a challenge for health and social care systems especially in context of global population ageing. They are complex and interrelated concepts in the care of older people that require early detection and patient centred decision making that are underpinned by the principles of multidisciplinary led comprehensive geriatric assessment (CGA). Personalised care plans need to remain responsive and adaptable to the needs of a patient, enabling an individual to maintain their independence.
Keywords
multi-morbidity; CGA; frailty; polypharmacy; deprescribing
Subject
Public Health and Healthcare, Primary Health Care
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment